In previous studies, DEX proved to suppress cell invasion in bladder cancer [68], inhibited hypoxia-induced EMT in colon cancer cells [69], and reduced TGF-β-induced EMT in non-malignant cells [70]. The gene discussed is TGFB1; the disease is urinary bladder cancer.